European Groundshot—addressing Europe's cancer research challenges: a Lancet Oncology Commission

Insights into the Relationship between Pentraxin-3 and Cancer

“…In 2022, 609,360 cancer deaths are predicted in the United States of America [ 163 ] and 1,269,200 cancer deaths in the European Union [ 164 ]; therefore, cancer research is important for effective prevention; earlier diagnosis; delivering safer, better, and potentially more affordable therapies [ 165 ]. Although inflammatory host response represents an important weapon in various physiological situations, when it becomes chronic, it may also contribute to cancer pathogenesis.…”

Pandemic delay: social implications and challenges for palliative care

“…The pandemic has brought predictions of palliative care patient ‘surges’, of increasing numbers of ‘avoidable deaths’, and of changes in the clinical and demographic profiles of patients who require palliative care. 1 , 4 Research has already highlighted reductions in urgent referrals for suspected cancer during 2020, related to significantly less patients consulting with general practiotioners (GPs). 5 Fewer presentations to primary care, and thus fewer referrals and diagnosis, have been reported as consequences of lockdowns and other pandemic-driven non-pharmaceutical interventions.…”

“…However, more recent attention has turned to longer-term implications of these measures and ‘living with COVID’, including The Lancet Oncology Commission ’s report into the unintended consequences for cancer diagnosis, care, and treatment. 1 As we approach the 3-year milestone since the onset of COVID-19, we enter a period when the effects of pandemic-related protections and containment measures become noticeably more visible. This is especially true in circumstances where patients, their families, and their health professionals, are grappling with the effects of what have been called pandemic delays .…”

“…3 To better understand these effects, existing models and language around diagnosis delay and help-seeking are being repurposed to understand experiences of delay during the first 3 years of the pandemic. 1 What has had less attention is how the social, cultural, and political context affects, and has been affected by, changes to diagnostic processes and palliative provision.…”

El enigma del coronavirus – Reinfecciones por COVID-19, COVID prolongado – Vacunas bivalentes - La gestante – Derechos humanos y Ética

“…Debido al COVID-19 se calcula que, en los últimos 2 años, un millón de casos de cáncer han pasado desapercibidos en toda Europa. Solo en el primer año, los médicos vieron 1,5 millones menos de pacientes con cáncer y 1 de cada 2 personas con cáncer sufrió retrasos en la administración del tratamiento (15) .…”